ACOG (Alpha Cognition) Volatility: 46.22% (As of Jun. 24, 2026)


ACOG Alpha Cognition Inc ACOG
32 GF Score
Price $6.59
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition Volatility?

Alpha Cognition ACOG +0.08% 32 Volatility is 46.22% as of Jun. 24, 2026. GuruFocus rates ACOG with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-06-24), Alpha Cognition's Volatility is 46.22%.

Alpha Cognition  (NAS:ACOG) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Alpha Cognition Volatility Related Terms

ACOG vs GNLX, VTVT, CRDF: Volatility Comparison

For the Biotechnology subindustry, Alpha Cognition's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Cognition Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Volatility distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Volatility falls into.


ACOG
32GF Score
Alpha Cognition Inc ACOG
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition  (NAS:ACOG) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * √12
=√ 1/(n-1) ∑(Ri - R')^2 * √12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 46.22% mean?
Alpha Cognition (ACOG) has a Volatility of 46.22% as of Jun. 24, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Alpha Cognition and its competitors.
Is Alpha Cognition's Volatility too high?
Alpha Cognition's current Volatility is 46.22%. Overall, Alpha Cognition has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's Volatility compare to GNLX and VTVT?
Alpha Cognition's Volatility of 46.22% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Alpha Cognition and its competitors. Alpha Cognition's current Volatility is 46.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current Volatility of 46.22%. The current Volatility is 46.22%. Alpha Cognition's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current Volatility is 46.22% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score

Get the complete analysis for ACOG

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.59
Price